NEDD9 and B-cell chronic lymphocytic leukemia: Indeed, we observed a tendency of reduced level of acetylated cortactin (AcCTTN) upon CXCL12 treatment in murine CLL cells with intact NEDD9 (Fig. 6B, C, left).